Mycozyl AL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Mycozyl AL
Generic name: TOLNAFTATE
Manufacturer: PURETEK CORPORATION
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 07edd043-4ac4-b2de-e063-6394a90af25d
SPL ID: 07edd043-4ac5-b2de-e063-6394a90af25d
Version: 1
Effective date: 2023-10-17
Source export date: 2026-10-30
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/772d0e4623a189b47f3ab71d7d51f9b3c89c5526f4cf3d218e1c921bb964b80c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:28:27

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Mycozyl AL	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		PURETEK CORPORATION	openfda.manufacturer_name
ndc	package	59088-443-01	openfda.package_ndc
ndc	product	59088-443	openfda.product_ndc
ndc11	package	59088044301	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		07edd043-4ac5-b2de-e063-6394a90af25d	id
spl set id		07edd043-4ac4-b2de-e063-6394a90af25d	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

WARNINGS: For External Use Only. Not For Ophthalmic Use

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: For athlete’s foot and ringworm - if irritation occurs or there is no improvement within 4 weeks. For prevention of athlete’s foot – if irritation occurs, discontinue use and consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.